ELTP needs movement

it's difficult to make a buck in the pharma industry these days.  the internet has turned the stock market into a deadly vicious uncaring death pool waiting for you to be tempted to take a dip.  elite pharmaceuticals has been disappointing during the last 12 months, but it is not for apparent bad leadership.  obviously, Hakim made forecasts and did it in a bold, confident manner.  the FDA made him eat his words but thankfully Hakim stays positive without letting delays and rejection skew his path.  but it is so quiet lately, and the movement on the share price has been disappointing despite progress with the pipeline. 

here is a sample of posts from the day:

from: Inthe203  

HERE IS ONE ISSUE WITH THIS DRUG

CLINICAL TRIAL ISSUE:

With a fatty diet and the consumption of one pill, the patient had the sense that the drug wasn't 'kicking in' or effectively working. The patient will then take ANOTHER ONE or even a THIRD and still not receive the maximum effect of that first pill taken. IN THE MEANTIME, now three pills are consumed and the patient is now in jeopardy of an actual overdose without realizing it.

THIS IS WHY the FDA denied the approval.

THE FDA also clearly stated in their response that putting a WARNING LABEL on the bottle will NOT suffice, which poses a HUGE problem for ELTP.

There's no conceivable way around this issue. This is ONE of prominent loopholes ELTP is struggling with and unless the company is physically present to tell the consumer to watch their eating habits, this simply isn't going to end well.

As an investor, i'm extremely disappointed. I'm guilty of putting all my eggs in one basket (just shy of 7M shares) and i'm stuck holding the bag.

I'm looking for a miracle and NO ONE can challenge me on this. I'm simply telling you factual information that came out of the mouth of the FDA!

$ELTP$ 

by:  WeeZuhl

40,000 ER docs in the U.S. with at least as many NP/PA's working in the ED, probably a lot more. Approx 80,000 E.R. providers.

Now add in Urgent Care. 10,000 urgent care clinics in the U.S. Each clinic probably has an average four docs and as many NP/PA's, so we'll approximate another 80,000 urgent care providers.

Approximately 160,000 E.R. and urgent care providers in the U.S.. We convince just 10% to switch to SequestOx, and they write an average of one script per shift- about 20 scripts in a month of 20 pills each.

160,000 x 10% = 16,000

16,000 x 20 scripts x 20 pills x 12 months = 76,800,000 capsules per year.

Now set your price. Say $5/capsule (approx. 5x of generic oxy capsules).

76,800,000 capsules x $5/cap = $384,000,000 / year in revenue just from 10% of ER and urgent care providers writing 1 SequestOx #20 script per shift.

Now what happens if you get buy-in from 25% of the those providers? 50%? Now start to add in pain management, primary care, and orthopedics. 

by: aELmTPa  

The modified formula is already complete and trials have started comparing the new formula to the old one.

Elite will proceed immediately to complete in vitro and in vivo bridging studies required and expects to resubmit the SequestOxTM application later this year. The in vivo studies include bioequivalence and bioavailability fed and fasted studies comparing the modified formulation to the original formulation.

the modified formulation

the modified formulation

the modified formulation